Spectrum Pharmaceuticals, Inc.SPPI announced that it has withdrawn the biologics license application ("BLA") seeking approval for its neutropenia candidate, Rolontis. The company stated that the ...
DUBLIN, Nov. 19, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics License ...
Immunomedics, Inc. IMMU announced that the FDA has accepted the biologics license application (BLA) for its most advanced candidate sacituzumab govitecan, an antibody-drug conjugate. The company is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback